Literature DB >> 34741610

SGLT2 inhibitors: the statins of the 21st century.

Eugene Braunwald1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34741610     DOI： 10.1093/eurheartj/ehab765

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

Review 1.  Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models.

Authors:  Sandra Feijóo-Bandín; Alana Aragón-Herrera; Manuel Otero-Santiago; Laura Anido-Varela; Sandra Moraña-Fernández; Estefanía Tarazón; Esther Roselló-Lletí; Manuel Portolés; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 2.  The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients.

Authors:  Israel Mazin; Fernando Chernomordik; Paul Fefer; Shlomi Matetzky; Roy Beigel
Journal:  J Clin Med       Date:  2022-03-29       Impact factor: 4.241

3.  Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality.

Authors:  Hugo Pomares-Millan; Alaitz Poveda; Naemieh Atabaki-Pasdar; Ingegerd Johansson; Jonas Björk; Mattias Ohlsson; Giuseppe N Giordano; Paul W Franks
Journal:  Nutrients       Date:  2022-08-01       Impact factor: 6.706

4.  Sodium-glucose Co-transporter-2 inhibitors (SGLT2I): A class of drugs with promising cardiorenal protective effects beyond glycemic control.

Authors:  Abdullah Zaawari; Aaminah Najmus Sahar
Journal:  Ann Med Surg (Lond)       Date:  2022-09-03

Review 5.  The Benefit of Sodium-Glucose Co-Transporter Inhibition in Heart Failure: The Role of the Kidney.

Authors:  Edoardo Gronda; Emilio Vanoli; Massimo Iacoviello; Pasquale Caldarola; Domenico Gabrielli; Luigi Tavazzi
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.